3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives.
As various substances of abuse come under Drug Enforcement Administration (DEA) Schedule restrictions, slightly modified derivatives (designer drugs) replace them. A series of amphetamine derivatives are discussed in this presentation. Applicable analytical methods are presented. Details of cases handled by the office (hospital patients, driving while under the influence/driving under the influence of drugs [DWI/DUID], and medical examiner cases) are discussed.
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives / Q000032:analysis* / Q000506:poisoning; D000328:Adult; D000435:Alcoholic Intoxication / Q000150:complications; D000662:Amphetamines / Q000032:analysis* / Q000506:poisoning; D001334:Automobile Driving; D002423:Cause of Death; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D005554:Forensic Medicine; D006801:Humans; D013287:Illicit Drugs / Q000032:analysis* / Q000506:poisoning; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine
D000662:Amphetamines; D013287:Illicit Drugs; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine